Rationale and Design of Two, Phase 3, Randomized Controlled Trials (COUGH-1 and COUGH-2) of Gefapixant, A P2x3 Receptor Antagonist, in Refractory and Unexplained Chronic Cough
D. Muccino, A. Morice, S. Birring, L. Mcgarvey, P. Dicpinigaitis, I. Pavord, A. Tershakovec, M. Kitt, Y. Zheng, C. Assaid, Jacky A. Smith
{"title":"Rationale and Design of Two, Phase 3, Randomized Controlled Trials (COUGH-1 and COUGH-2) of Gefapixant, A P2x3 Receptor Antagonist, in Refractory and Unexplained Chronic Cough","authors":"D. Muccino, A. Morice, S. Birring, L. Mcgarvey, P. Dicpinigaitis, I. Pavord, A. Tershakovec, M. Kitt, Y. Zheng, C. Assaid, Jacky A. Smith","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4700","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":160937,"journal":{"name":"C37. SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS","volume":"305 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"C37. SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4700","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}